Drug
Miravirsen clinical trials
Also written SPC3649.
Includes 2 studies of Miravirsen sodium.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
6 studies that test it; most in 2012 (2)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Santaris Pharma A/S (6)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses miravirsen is read from its arms, and is right about nine times in ten.
Testing it · 6
- Miravirsen in Combination With Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus InfectionStatus unknownPhase 2Santaris Pharma A/SNCT01872936Written as Miravirsen
- Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis CStatus unknownPhase 2Santaris Pharma A/SNCT01727934Written as Miravirsen sodium
- Drug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy SubjectsCompletedPhase 1Santaris Pharma A/SNCT01646489Written as Miravirsen sodium
- Multiple Ascending Dose Study of Miravirsen in Treatment-Naïve Chronic Hepatitis C SubjectsCompletedPhase 2Santaris Pharma A/SNCT01200420Written as miravirsen
- SPC3649 Multiple Dose Study in Healthy VolunteersCompletedPhase 1Santaris Pharma A/SNCT00979927Written as SPC3649
- Safety Study of SPC3649 in Healthy MenCompletedPhase 1Santaris Pharma A/SNCT00688012Written as SPC3649
Codes
What other systems call miravirsen · ClinicalTrials.gg INT006281
- MeSH (NLM) C581159miravirsenOne source NLM
- UNII (FDA) Q083AJW7VSMIRAVIRSENConfirmed FDA, NLM
- NCI Thesaurus C174858MiravirsenOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C581159 | miravirsen | One source NLM |
| UNII (FDA) | Q083AJW7VS | MIRAVIRSEN | Confirmed FDA, NLM |
| NCI Thesaurus | C174858 | Miravirsen | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.